Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$980M |
| 2 |
Humana
HUM
|
+$637M |
| 3 |
Apple
AAPL
|
+$620M |
| 4 |
Home Depot
HD
|
+$541M |
| 5 |
Microsoft
MSFT
|
+$539M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$770M |
| 2 |
McDonald's
MCD
|
+$654M |
| 3 |
Cigna
CI
|
+$498M |
| 4 |
Digital Realty Trust
DLR
|
+$430M |
| 5 |
Amazon
AMZN
|
+$429M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.91% |
| 2 | Healthcare | 3.33% |
| 3 | Consumer Discretionary | 2% |
| 4 | Industrials | 1.79% |
| 5 | Financials | 1.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
12451
PUT
BioVie
BIVI
$10.6M
| $22.2K | ﹤0.01% |
65
-96
| -60% | -$37.5K |
|
|
EGRX
12452
CALL
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $22.1K | ﹤0.01% |
1,400
-1,500
| -52% | -$26.9K |
|
12453
PUT
Invesco S&P 500 Pure Value ETF
RPV
$1.75B
| $22.1K | ﹤0.01% |
300
| – | – |
|
|
MTVA
12454
MetaVia Inc
MTVA
$7.69M
| $22.1K | ﹤0.01% |
+527
| New | +$23.5K |
|
|
ASTR
12455
CALL
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
| $22.1K | ﹤0.01% |
11,931
+284
| +2% | +$1.23K |
|
|
ZH
12456
CALL
Zhihu
ZH
$272M
| $22K | ﹤0.01% |
3,533
-34
| -1% | -$222 |
|
12457
PUT
BigBear.ai
BBAI
$1.57B
| $22K | ﹤0.01% |
14,600
-8,700
| -37% | -$15.1K |
|
|
DENN
12458
PUT
DELISTED
Denny's
DENN
| $22K | ﹤0.01% |
2,600
-18,600
| -88% | -$188K |
|
|
INBX
12459
PUT
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $22K | ﹤0.01% |
1,200
-3,900
| -76% | -$81.6K |
|
12460
PUT
SelectQuote
SLQT
$129M
| $22K | ﹤0.01% |
18,800
+2,600
| +16% | +$3.93K |
|
12461
CALL
DarioHealth
DRIO
$74.3M
| $22K | ﹤0.01% |
335
-265
| -44% | -$17.9K |
|
12462
Sol-Gel Technologies
SLGL
$277M
| $21.9K | ﹤0.01% |
1,344
-431
| -24% | -$12.4K |
|
|
KE
12463
PUT
Kimball Electronics
KE
$622M
| $21.9K | ﹤0.01% |
800
-800
| -50% | -$22.9K |
|
|
CMRX
12464
PUT
DELISTED
Chimerix, Inc.
CMRX
| $21.9K | ﹤0.01% |
22,800
+11,700
| +105% | +$12.7K |
|
12465
CALL
nLIGHT
LASR
$3.03B
| $21.8K | ﹤0.01% |
2,100
-9,700
| -82% | -$118K |
|
12466
Comstock
LODE
$263M
| $21.8K | ﹤0.01% |
5,326
+4,417
| +486% | +$22.9K |
|
12467
PUT
Grove Collaborative
GROV
$44M
| $21.8K | ﹤0.01% |
+8,200
| New | +$20.8K |
|
|
SNT
12468
Senstar Technologies
SNT
$42.9M
| $21.8K | ﹤0.01% |
19,644
+1,984
| +11% | +$2.37K |
|
12469
PUT
Runway Growth Finance
RWAY
$290M
| $21.8K | ﹤0.01% |
1,700
-12,700
| -88% | -$163K |
|
12470
PUT
LeMaitre Vascular
LMAT
$1.88B
| $21.8K | ﹤0.01% |
400
-300
| -43% | -$17.8K |
|
12471
PUT
State Street SPDR Portfolio Europe ETF
SPEU
$743M
| $21.7K | ﹤0.01% |
+600
| New | +$22.8K |
|
12472
PUT
SCYNEXIS
SCYX
$51.5M
| $21.7K | ﹤0.01% |
1,188
+650
| +121% | +$15.5K |
|
12473
PUT
Newegg Commerce
NEGG
$392M
| $21.6K | ﹤0.01% |
1,280
-240
| -16% | -$5.58K |
|
12474
CALL
LENSAR
LNSR
$101M
| $21.6K | ﹤0.01% |
+7,000
| New | +$24K |
|
12475
Akanda
AKAN
$3.49M
| $21.6K | ﹤0.01% |
+7
| New | +$24.2K |
|
Similar funds
Ken Griffin's Q3 2023 Portfolio in Review
As of Q3 2023, Ken Griffin held 15,669 positions worth $467B, down 3.6% from $484B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Ken Griffin's Q3 2023 filing shows 1,406 new, 6,433 increased, 6,116 reduced and 1,460 closed positions. Its largest new stake was Arm: 3,445,206 shares worth $184M. The largest sale was Invesco QQQ Trust, an estimated $770M.
By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Ken Griffin's largest Q3 2023 buy was Arm: 3,445,206 shares worth $184M.
- Ken Griffin added most to Activision Blizzard in Q3 2023, an estimated $980M increase.
- Ken Griffin's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $770M.
- Ken Griffin fully exited Coca-Cola Europacific Partners in Q3 2023, selling an estimated $124M.
- Ken Griffin's ten largest holdings make up 33% of its $467B portfolio in Q3 2023.
- Ken Griffin opened 1,406 new positions and closed 1,460 in Q3 2023.
- Ken Griffin's portfolio value fell 3.6% quarter-over-quarter to $467B.
Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.